Can maternofetal transfusion provoke adverse outcomes akin to TA-GVHD?

There exists a need to research new diagnostic and therapeutic approaches that consider hemolytic disease of fetus and newborn (HDFN)’s physiopathology and focus not only on the pregnant person’s immune system but also on the fetal immune system. This implies, in the final sense, to view the fetus as our patient. In spite of having found a safe and efficient method of prevention of HDFN more than 50 years ago, HDFN continues to be a relevant cause of perinatal morbidity and mortality, due to lack of access to immunoprophylaxis. In light of the above, we should strive to prevent sensitization and HDFN by ensuring certain health policies across the globe, especially in countries and regions of high morbidity and mortality.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Can maternofetal transfusion provoke adverse outcomes akin to TA-GVHD?

Cited by 3 publications

References 41 publications

Guest Editorial: Two hits and four factors affecting the development of, or resistance to, transfusion-associated graft-versus-host disease

Guest Editorial: Two hits and four factors affecting the development of, or resistance to, transfusion-associated graft-versus-host disease

A Case of Fetal-Induced Graft-versus-Host Disease

Hemolytic disease of the fetus and newborn: pregnant person’s and fetal immune systems interaction

Contact Info

Product

Resources

About